GEG
Great Elm Group, Inc.
There isn't enough reported data to score GEG yet.
LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
GEG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Healthy | |
| Strong |
GEG's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is weak.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
GEG PE Valuation
GEG has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
GEG Forward outlook
There aren't enough analyst estimates for GEG to show an outlook.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
GEG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.07 | -1883% |
| Q2 2026 | -$1.17 | -408% |
| Q1 2026 | -$0.76 | -$0.69 |
| Q4 2025 | -$0.48 | -$0.48 |
| Q3 2025 | $0.06 | +$0.11 |
| Q2 2025 | $0.38 | +$0.43 |
| Q1 2025 | -$0.07 | +$0.08 |
| Q4 2024 | $0.00 | -100% |
GEG has swung to a loss: it lost $1.07 per share over the past year, after a profit the year before.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over GEG on earnings quality, reporting a profit while its opponent remains loss making.
GEG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.3M | -69% |
| Q2 2026 | $10.6M | +88% |
| Q1 2026 | $3.4M | +6.5% |
| Q4 2025 | $3M | -14% |
| Q3 2025 | $10.8M | +170% |
| Q2 2025 | $5.6M | -37% |
| Q1 2025 | $3.2M | +15% |
| Q4 2024 | $3.5M | +24% |
GEG's revenue has slid since its 2022 peak: $3M last quarter, down 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -104% | -70 points |
| Q2 2026 | -20% | +6.6 points |
| Q1 2026 | -116% | -37 points |
| Q4 2025 | -141% | -84 points |
| Q3 2025 | -35% | +16 points |
| Q2 2025 | -26% | -5.9 points |
| Q1 2025 | -80% | -13 points |
| Q4 2024 | -56% | +39 points |
GEG's operating margin was −104% last quarter, down 70 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over GEG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over GEG on profitability, with a higher operating margin.
GEG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$10.6M | -378% |
| Q2 2026 | $7.9M | +265% |
| Q1 2026 | $5.8M | +$7.2M |
| Q4 2025 | -$1.9M | +$2.2M |
| Q3 2025 | $3.8M | +$9.6M |
| Q2 2025 | $2.2M | -27% |
| Q1 2025 | -$1.3M | -198% |
| Q4 2024 | -$4M | +$9.7M |
GEG usually generates cash, though not every quarter: the latest was −$11M, but it generated $1M over the past year.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over GEG on cash flow, with more consistent year-over-year improvement.
GEG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.8% | -554K shares |
| 1 year | +2.6% | +763K shares |
| 3 years | +2.5% | +738K shares |
| 5 years | +15% | +4M shares |
| Available history | +17% | +4.3M shares |
GEG has 30M diluted shares, up 2.6% from a year ago, despite $7M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $581,000 |
| Q2 2026 | $596,000 |
| Q1 2026 | $2.8M |
| Q4 2025 | $2.6M |
| Q3 2025 | $756,000 |
| Q2 2025 | $922,000 |
| Q1 2025 | $1.1M |
| Q4 2024 | $3.1M |
GEG spent $7M buying back its own shares over the past year, up 13% from the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over GEG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
GEG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | -15.6x | Net Cash |
| Q1 2022 | -12.4x | Net Cash |
| Q4 2021 | -6.4x | Net Cash |
| Q3 2021 | -4.3x | Net Cash |
| Q4 2019 | 8.6x | High |
GEG has more cash than debt.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
GEG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 22.8 | Neutral |
GEG's weekly RSI is 48 (neutral) and its Stochastic is 23 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
GEG PE vs Healthcare Sector
| Metric | GEG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
GEG has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
GEG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.16 | 0% above |
| 20 week MA | $2.17 | 0.5% below |
| 50 week MA | $2.20 | 1.8% below |
| 100 week MA | $2.17 | 0.5% below |
| 200 week MA | $2.06 | 4.9% above |
GEG has fallen below most of its moving averages, though it's still 4.9% above its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over GEG on trend strength, trading above more of its moving averages.
GEG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.48 | $2.72 | -22% |
| 2021 | $2.72 | $2.07 | -24% |
| 2022 | $2.07 | $1.99 | -3.9% |
| 2023 | $1.99 | $1.94 | -2.5% |
| 2024 | $1.94 | $1.82 | -6.2% |
| 2025 | $1.82 | $2.44 | +34% |
| 2026 YTD | $2.44 | $2.16 | -11% |
GEG has finished lower in five of the last six years. It's down 11% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over GEG on returns for 2026, with the stronger performance.